MR spectroscopy in radiation injury

American Journal of Neuroradiology

Volumn 30, Issue 8, 2009, Pages 1469-1476

  Sundgren, Pia C ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHOLINE; CREATINE; FATTY ACID; LACTIC ACID; N ACETYLASPARTIC ACID;

BRAIN TUMOR; CLINICAL DECISION MAKING; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION INJURY; RADIATION NECROSIS; REVIEW; SCINTIGRAPHY; TUMOR RECURRENCE;

ALGORITHMS; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY, CONFORMAL; TUMOR MARKERS, BIOLOGICAL;

EID: 70349222766     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1580     Document Type: Review

References (72)

1. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731 (Pubitemid 10187518)
2. Johannesen TB, Lien HH, Hole KH, et al. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol 2003;69:169-176
3. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol 1999;30:125-131
4. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000;41:1861-1867
5. Terakawa Y, Tsuyuguchi N, Iwai Y, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008;49:694-699 (Pubitemid 351717532)
6. Hein PA, Eskey CJ, Dunn JF, et al. Diffusion-weighted imaging in the follow- up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004;25:201-209
7. Sundgren PC, Fan X, Weybright P, et al. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast enhancing lesions. Magn Reson Imaging 2006;24:1131-1142 Epub 2006 Sep 18 (Pubitemid 44635065)
8. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901-909 (Pubitemid 30262837)
9. Jain R, Scarpace L, Ellika S, et al. First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 2007;61:778-786 (Pubitemid 350073285)
10. Di Chiro G, Oldfield E, Wright DC. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 1988;150:189-197 (Pubitemid 18027033)
11. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neurosurg 1999;73:9-14 (Pubitemid 30344992)
12. Carvalho PA, Schwartz RB, Alexander E, et al. Detection of recurrent gliomas with qualitative thallium-201/technetium 99m HMPAO single-photon emission computerized tomography. J Neurosurg 1992;77:565-570
13. Schwartz RB, Carvalho PA, Alexander E, et al. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dualisotope SPECT with 201Tl and 99mTc-HMPAO. AJNR Am J Neuroradiol 1991;12:1187-1192
14. Schwartz RB, Holman BL, Polak JF, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998;89:60-68
15. Matheja P, Rickert C, Weckesser M, et al. Scintigraphic pitfall: delayed radionecrosis - case illustration. J Neurosurg 2000;92:732 (Pubitemid 30180686)
16. Barajas RF, Chang JS, Sneed PK, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusionMR imaging. AJNR Am J Neuroradiol 2009;30:367-372 Epub 2008 Nov 20
17. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-384
18. Marks JE, Baglan RJ, Prassad SC, et al. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981;7:243-252
19. Belka C, Budach W, Kortmann RD, et al. Radiation-induced CNS toxicity: molecular and cellular mechanisms. Br J Cancer 2001;85:1233-1239 (Pubitemid 33081913)
20. Sawaya R. The fibrinolytic enzymes in the biology of brain tumors. In: Swaya MD, ed. Fibrinolysis and the Central Nervous System. Philadelphia: Hanley and Belfus; 1990:106-126
21. Castel JC, Caille JM. Imaging of irradiated brain tumors: value of magnetic resonance imaging. J Neuroradiol 1989;16:81-132 (Pubitemid 20026084)
22. Burger PC, Boyko OB. The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, eds. Radiation Injury to the Nervous System. New York: Raven; 1991:191-208
23. Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol 2006;24:884-890
24. Moretti R, Torre P, Antonello RM, et al. Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci 2005;229 -230:195-200. Epub 2004 Dec 19 (Pubitemid 40341583)
25. Cole PD, Kamen BA. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006;12:174-183 (Pubitemid 44646326)
26. Herman MA, Tremont-Lukats I, Meyers CA, et al. Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol 2003;26:273-279 (Pubitemid 36712643)
27. Constine LS, Konski A, Ekholm S, et al. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 1988;15:319-330 (Pubitemid 18212161)
28. Packer RJ, Zimmerman RA, Bilaniuk LT. Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 1986;58:635-640 (Pubitemid 16072064)
29. Price RE, Langford LA, Jackson EF, et al. Radiation-induced morphologic changes in the rhesus monkey (Macaca mulatta) brain. J Med Primatol 2001;30:81-87 (Pubitemid 32633534)
30. Benczik J, Tenhunen M, Snellman M, et al. Late radiation effects in the dog brain: correlation of MRI and histological changes. Radiother Oncol 2002;63:107-120 (Pubitemid 34626762)
31. Chiang CS, McBride WH, Withers HR. Myelin-associated changes in mouse brain following irradiation. Radiother Oncol 1993;27:229-236 (Pubitemid 23270049)
32. Burger PC, Mahley MS Jr, Dudka L, et al. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 1979;44:1256-1272 (Pubitemid 10197395)
33. Armstrong CL, Gyato K, Awadalla AW, et al. A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychol Rev 2004;14:65-86 (Pubitemid 39023957)
34. Mikhael MA. Radiation necrosis of the brain: correlation between patterns on CT and dose of radiation. J Comput Assist Tomogr 1979;3:241-249 (Pubitemid 9182957)
35. Nagesh V, Tsien CI, Chenevert TL, et al. Radiation-induced changes in normalappearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. Int J Radiat Oncol Biol Phys 2008;70:1002-1010 (Pubitemid 351296105)
36. Sundgren PC, Nagesh V, Elias A, et al. Metabolic alterations: a biomarker for radiation-induced injury of normal brain-a spectroscopy study. J Magn Reson Imaging 2009;29:291-297
37. Lee MC, Pirzkall A, McKnight TR, et al.1H-MRSof radiation effects in normalappearing white matter: dose-dependence and impact on automated spectral classification. J Magn Reson Imaging 2004;19:379-388 (Pubitemid 38437144)
38. Tofilon PJ, Fike JR. The radioresponse of the central nervous system: a dynamic process. Radiat Res 2000;153:357-370 (Pubitemid 30185388)
39. Bates TE, Strangeward M, Keelan J, et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1992;7: 1397-1400
40. de Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-727
41. Estève F, Rubin C, Grand S, et al. Transient metabolic changes observed with protonMRspectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998;40:279-286
42. Chan YL, Roebuck DJ, Yuen MP, et al. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys 2001;50:759-763
43. Isobe T, Matsumura A, Anno I, et al. Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline- containing compounds [in Japanese]. No Shinkei Geka 2003;31:167-172
44. Walecki J, Sokó l M, Pieniazek P, et al. Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients. Eur J Radiol 1999;30: 154-161 (Pubitemid 29281716)
45. Kitahara S, Nakasu S, Murata K, et al. Evaluation of treatment-induced cerebral white matter injury by using diffusion-tensor MR imaging: initial experience. AJNR Am J Neuroradiol. 2005;26:2200-2206
46. Sundgren PC, Rogers L, Tsien CT, et al. Correlation of Magnetic Resonance Imaging Morphologic Abnormalities, Magnetic Resonance Spectroscopy and Radiation Treatment Dose-Volumes in Histological Proven Cerebral Radiation Necrosis. Proceedings of the European Society of Neuroradiology, Krakow, Poland, September 18-21, 2008
47. Chong VF, Rumpel H, Fan YF, et al. Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 2001;11:317-324 (Pubitemid 32755455)
48. Chong VF, Rumpel H,AwYS, et al. Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J Radiat Oncol Biol Phys 1999;45:699-705
49. Schlemmer JP, Bachert P, Henze M, et al. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 2002;44:216-222 (Pubitemid 36075911)
50. Schlemmer HP, Bachert P, Herfarth K, et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001;22:1316-1324 (Pubitemid 32734804)
51. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15
52. Yeung DK, Chan Y, Leung S, et al. Detection of an intense resonance at 2.4ppm in 1H MR spectra of patients with severe late-delayed, radiation-induced brain injuries. Magn Reson Med 2001;45:994-1000
53. Rock JP, Scarpace L, Hearshen D, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004:54;1111-1119 (Pubitemid 38585925)
54. Weybright P, Sundgren PC, Maly P, et al. Differentiation between brain tumour recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005;185:1471-1476
55. Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002;51:912-919 (Pubitemid 36331026)
56. Zeng QS, Li CF, Zhang K, et al. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007;84: 63-69
57. Kimura T, Sako K, Gotoh T, et al. In vivo single voxel protonMRspectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001;14:339-349 (Pubitemid 32982698)
58. Kimura T, Sako K, Tohyama Y, et al. Diagnosis and treatment of progressive space-occupying radiation necrosis following radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy. Acta Neurochir 2003;145:557-564 (Pubitemid 37093957)
59. Rutkowski T, Tarnawski R, Sokol M, et al. Proton-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 2003;56:1381-1389 (Pubitemid 36842891)
60. Weybright P, Maly P, Gomez Hassan D, et al. MR spectroscopy in the evaluation of recurrent contrast enhancing lesions in the posterior fossa after tumor treatment. Neuroradiology 2004;46:541-559 (Pubitemid 39144788)
61. Bulakbasi N, Kocaoglu M, Ors F, et al. Combination of single-voxel protonMR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24:225-233 (Pubitemid 36237173)
62. Lin A, Bluml S, Mamelak AN. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999;45:69-81 (Pubitemid 30142443)
63. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002; 44:656-666 (Pubitemid 36075928)
64. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525-534 (Pubitemid 27430398)
65. Kinoshita K, Tada E, Matsumoto K, et al. Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy. AJNR Am J Neuroradiol 1997;18:1753-1761 (Pubitemid 30399780)
66. Croteau D, Scarpace L, Hearshen D, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and quantitative histopathological analyses of patients with untreated glioma. Neurosurgery 2001;49:823-829 (Pubitemid 32927953)
67. Lazareff JA, Gupta RK, Alger J. Variation of post-treatment H-MRSI choline signal intensity in pediatric gliomas. J Neurooncol 1999;41:291-298 (Pubitemid 29209818)
68. McKnight TR, von dem Busche MH, Vigneron DB, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002;97:794-802
69. Elias A, Carlos RC, Smith E, et al. MR Spectroscopy Using Normalized and Non- Normalized Metabolite Ratios for Differentiating Recurrent Brain Tumor from Radiation Injury. Proceedings of the Radiological Society of North America, Chicago, Ill, November 30-December 5, 2008
70. Lin A, Mamelak A, Ross BD. Effect of MRS on Clinical Decision Making in Brain Tumour Management. Proceedings of the International Society of Magnetic Resonance in Medicine, Denver, Colo, April 1-7, 2000
71. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' Guides to Medical Literature XXV: evidence-based medicine-principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000;284: 1290-1296
72. Smith EA, Carlos RC, Junck LR, et al. Developing a clinical decision model: use of MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast enhancing lesions. AJR Am J Roentgenol 2009;192:W45-52